RxDoctor Payments Data

Andrew Hill

Family · Greenville, NCNPI 1285282244

Payments from drug & device makers

$6,511in general payments, 2019–2025

Across 71 payments — averaging $91.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Fresenius USA Marketing, Inc.$5K
  • AstraZeneca$722
  • Vifor Pharma, Inc.$211
  • Nxstage Medical, Inc.$135
  • GSK$97
  • Calliditas Therapeutics US Inc.$77
  • plus $402 from 12 others

What the payments were for

  • Consulting fees$3,00046%
  • Travel & lodging$94615%
  • Food & beverage$2,51839%
  • Education$471%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,511 in reported general payments places this provider in the 95th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$58,486
Medicare patients
315
Services billed
2,507

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VelphoroSucroferric Oxyhydroxide12$43,219
AuryxiaFerric Citrate22$33,728
FarxigaDapagliflozin Propanediol17$13,916
Sevelamer Carbonate61$12,728
LokelmaSodium Zirconium Cyclosilicate15$6,184
Calcium Acetate14$392
Losartan Potassium46$333
Amlodipine Besylate35$245
Atorvastatin Calcium18$143
Carvedilol13$130
Omeprazole12$123
Lisinopril11$89
Torsemide12$74
Ciprofloxacin Hcl13$72
Furosemide17$41

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Fresenius USA Marketing, Inc.Velphoro$4,867$43,21912 claims
Akebia Therapeutics IncAuryxia$38$33,72822 claims
AstraZenecaFarxiga, Lokelma$722$20,10032 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,522 family providers in North Carolina.

Other family in Greenville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →